ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,455Medicare Part D Prescriptions Filled, Including Refills

Rank: 348 out of 1844

$518K Total Retail Price of All Prescriptions

Rank: 328 out of 1844

327 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 327 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 327 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 6,583 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 264 127 S3 1 2
METFORMIN HCL 208 154 2 8
LEVOTHYROXINE SODIUM 194 171 3 1
AMLODIPINE BESYLATE 193 177 4 6
FUROSEMIDE 185 162 5 7
LISINOPRIL 174 137 6 4
OMEPRAZOLE 149 101 7 5
SIMVASTATIN 145 122 8 3
PANTOPRAZOLE SODIUM 140 99 9 32
POTASSIUM CHLORIDE 139 125 10 16
WARFARIN SODIUM 133 127 11 13
DONEPEZIL HCL 128 126 12 26
NAMENDA 128 126 12 33
CITALOPRAM HBR 124 88 14 19
TRAMADOL HCL 120 107 15 18
SERTRALINE HCL 102 76 16 21
GABAPENTIN 93 78 17 15
POLYETHYLENE GLYCOL 3350 89 66 18 39
METOPROLOL TARTRATE 89 78 18 11
PAROXETINE HCL 87 58 20 68
ALLOPURINOL 86 73 21 29
ZOLPIDEM TARTRATE 85 57 22 23
METOPROLOL SUCCINATE 82 82 23 14
ATENOLOL 81 58 24 17
HYDROCHLOROTHIAZIDE 80 71 25 9
ATORVASTATIN CALCIUM 79 74 26 12
PRAVASTATIN SODIUM 79 56 26 10
SPIRIVA 78 73 28 57
BYSTOLIC 75 68 29 106
FENTANYL 74 48 S2 30 66
CYMBALTA 72 60 31 36
CEFUROXIME 72 51 31 184
CLONIDINE HCL 70 68 33 64
ESCITALOPRAM OXALATE 65 58 34 52
FLUOXETINE HCL 65 37 34 41
ADVAIR DISKUS 62 61 36 51
ROPINIROLE HCL 60 28 37 76
CLOPIDOGREL 59 45 38 34
FENOFIBRATE 57 45 39 71
ACETAMINOPHEN-CODEINE 57 57 S3 39 143
MELOXICAM 57 50 39 28
ENALAPRIL MALEATE 51 51 42 69
LIDODERM 50 50 43 155
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.